Supernus Pharmaceuticals (SUPN) Change in Taxes (2016 - 2020)

Supernus Pharmaceuticals (SUPN) has 5 years of Change in Taxes data on file, last reported at -$25.1 million in Q3 2020.

• On a quarterly basis, Change in Taxes fell 1268.42% year-over-year to -$25.1 million in Q3 2020; TTM through Sep 2020 was -$18.6 million, a 399.41% decrease from a year earlier, with the FY2019 full-year figure at -$9.9 million, down 178.97% from the prior year.
• Change in Taxes for Q3 2020 stood at -$25.1 million, down from $6.7 million in the prior quarter.
• Over the last five years, Change in Taxes for SUPN reached as high as $9.4 million in Q4 2017 and fell as low as -$25.1 million in Q3 2020.
• Historically, Change in Taxes has averaged -$886333.3 across 5 years, with a median of $554500.0 in 2016.
• Across the five-year window, Change in Taxes surged 7481.82% in 2017 and plunged 24176.12% in 2018, its largest moves.
• Year by year, Change in Taxes stood at -$804000.0 in 2016, then surged by 1275.25% to $9.4 million in 2017, then sank by 59.48% to $3.8 million in 2018, then sank by 162.03% to -$2.4 million in 2019, then tumbled by 954.78% to -$25.1 million in 2020.
• Per Business Quant data, the three most recent Change in Taxes figures were -$25.1 million in Q3 2020, $6.7 million in Q1 2020, and -$2.4 million in Q4 2019.